Apollo Endosurgery, Inc.
APEN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $77 | $63 | $42 | $51 |
| % Growth | 22% | 49.8% | -17.1% | – |
| Cost of Goods Sold | $34 | $28 | $20 | $25 |
| Gross Profit | $42 | $35 | $22 | $26 |
| % Margin | 55.2% | 55.5% | 52.9% | 50.6% |
| R&D Expenses | $12 | $10 | $8 | $10 |
| G&A Expenses | $21 | $18 | $11 | $14 |
| SG&A Expenses | $57 | $43 | $28 | $42 |
| Sales & Mktg Exp. | $36 | $24 | $17 | $29 |
| Other Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Expenses | $70 | $54 | $38 | $55 |
| Operating Income | -$28 | -$19 | -$16 | -$29 |
| % Margin | -36.2% | -30.5% | -37.6% | -57.4% |
| Other Income/Exp. Net | -$8 | -$5 | -$7 | $2 |
| Pre-Tax Income | -$39 | -$25 | -$22 | -$27 |
| Tax Expense | $1 | $0 | $0 | $0 |
| Net Income | -$40 | -$25 | -$23 | -$27 |
| % Margin | -51.8% | -39.2% | -53.8% | -54.1% |
| EPS | -0.98 | -0.82 | -0.99 | -1.27 |
| % Growth | -19.5% | 17.2% | 22% | – |
| EPS Diluted | -0.98 | -0.82 | -0.99 | -1.27 |
| Weighted Avg Shares Out | 41 | 30 | 23 | 22 |
| Weighted Avg Shares Out Dil | 41 | 30 | 23 | 22 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5 | $8 | $5 | $4 |
| Depreciation & Amortization | -$0 | $2 | $2 | $3 |
| EBITDA | -$31 | -$14 | -$12 | -$26 |
| % Margin | -40.9% | -22.5% | -28.3% | -51.7% |